(PIII) P3 Health Partners - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US7444131053

PIII: Healthcare, Clinics, Wellness, Population, Management

P3 Health Partners Inc. (NASDAQ:PIII) is a patient-centered and physician-led population health management company specializing in value-based care services across the United States. Founded in 2020 and headquartered in Henderson, Nevada, the company operates a network of clinics and wellness centers designed to deliver integrated healthcare solutions. P3 Health Partners focuses on improving health outcomes through preventive care, chronic disease management, and coordinated medical services. The company has expanded its footprint rapidly since its inception, emphasizing a data-driven approach to population health management.

From a technical perspective, PIII has shown declining momentum, with its SMA 20 and SMA 50 trending below the SMA 200, indicating bearish sentiment. The stocks average trading volume of 1.24 million shares over 20 days suggests moderate liquidity. The ATR of 0.02 reflects low volatility, while the last price of $0.18 is below its short-term moving averages, signaling potential weakness. Fundamental analysis reveals a market cap of $104.97 million, with a price-to-book ratio of 0.25, indicating undervaluation relative to book value. However, the negative return on equity (-85.21%) and lack of forward P/E suggest significant financial challenges.

3-Month Forecast: - Technical Outlook: - The stock is likely to remain under pressure, with potential resistance at $0.21 (SMA 50) and support at $0.15. - Expect continued range-bound trading with limited upside due to the bearish crossover of SMA 20 below SMA 50. - Fundamental Outlook: - P3 Health Partners may face operational headwinds due to its negative return on equity and lack of profitability. - The companys valuation multiples, such as P/S of 0.07, suggest limited upside unless it demonstrates significant revenue growth or margin improvement.

Additional Sources for PIII Stock

PIII Stock Overview

Market Cap in USD 3,651m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Equipment
IPO / Inception 2021-04-06

PIII Stock Ratings

Growth Rating -85.0
Fundamental -1.46
Dividend Rating 0.0
Rel. Strength -62.9
Analysts 4/5
Fair Price Momentum 3.86 USD
Fair Price DCF -

PIII Dividends

No Dividends Paid

PIII Growth Ratios

Growth Correlation 3m -56.1%
Growth Correlation 12m -93.9%
Growth Correlation 5y -95.9%
CAGR 5y -62.71%
CAGR/Max DD 5y -0.64
Sharpe Ratio 12m -1.39
Alpha -71.67
Beta 0.826
Volatility 98.44%
Current Volume 9.6k
Average Volume 20d 9.1k
What is the price of PIII stocks?
As of April 30, 2025, the stock is trading at USD 8.75 with a total of 9,560 shares traded.
Over the past week, the price has changed by -1.57%, over one month by +6.64%, over three months by -9.04% and over the past year by -62.63%.
Is P3 Health Partners a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, P3 Health Partners is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -1.46 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PIII as of April 2025 is 3.86. This means that PIII is currently overvalued and has a potential downside of -55.89%.
Is PIII a buy, sell or hold?
P3 Health Partners has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy PIII.
  • Strong Buy: 2
  • Buy: 0
  • Hold: 2
  • Sell: 0
  • Strong Sell: 0
What are the forecast for PIII stock price target?
According to ValueRays Forecast Model, PIII P3 Health Partners will be worth about 4.3 in April 2026. The stock is currently trading at 8.75. This means that the stock has a potential downside of -50.74%.
Issuer Forecast Upside
Wallstreet Target Price 31.3 257.1%
Analysts Target Price 31.3 257.1%
ValueRay Target Price 4.3 -50.7%